Does the presence and location of cerebral microbleeds affect your decision for antithrombotic treatment in patients with atrial fibrillation?   

Do you distinguish between primary and secondary prevention? Wilson et al., PMID 31130428 is helpful, but curious how people apply this data in practice.



Answer from: at Community Practice

Answer from: at Academic Institution

Answer from: at Academic Institution